Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Group Regulatory News (COST)

Share Price Information for Costain Group (COST)

Share Price is delayed by 15 minutes
Get Live Data
193.00    0.40 (0.21%)
Bid:
192.60
Ask:
193.20
Spread: 0.60 (0.312%)
Market Cap: £515.46m
COST Live PriceLast checked at - London Stock Exchange

Intraday Costain Group Share Chart

Trading Update

7 Jan 2014 07:00

RNS Number : 0232X
Costain Group PLC
07 January 2014
 



Costain Group PLC

("Costain" or "the Group" or "the Company")

 

Pre-Close Trading Update

 

Costain, a leading UK engineering solutions provider, today announces its pre-close trading update for the year ended 31 December 2013, ahead of its preliminary results for the period which will be announced on Thursday 13 March 2014.

 

Trading Update

 

Since the announcement of the Group's Interim Management Statement on 5 November 2013, Costain has continued to perform strongly and consequently expects to deliver a full-year result in line with the Board's expectations. In addition, as announced on 20 December 2013, the Group has realised a profit of £9.1 million from the sale of its minority shareholdings in three joint venture companies to Severn Trent PLC as part of the continuing disposal of its PFI equity portfolio. 

 

As a result of new contract wins and extensions, including the landmark AMP6 programme for Thames Water, the Hinkley Point C nuclear power station project, and a number of additional contracts for Crossrail, the Group finished the year with a high quality order book up 25% at £3.0 billion (2012: £2.4 billion) of which over 90% is repeat orders, providing good long-term revenue visibility. In excess of £750 million of work has been secured for 2014 (2012: in excess of £700 million secured for 2013).

 

In addition, Costain has a strong preferred bidder position on contracts worth over £400 million, and the level of tendering activity across the Group's targeted markets remains high.

 

The Group finished the year with a positive net cash position.

 

At the period end, the Group acquired the 27% interest from its partner Serco plc in their Managed Motorway Technology joint venture arrangement for a cash consideration of £2.4 million. The joint venture arrangement, in which Costain already held the remaining 73% interest, has a place on the Highways Agency framework to deliver new technology-led highways improvements.

 

Andrew Wyllie, Chief Executive, commented:

 

"We are delighted to finish the year with a very strong order book. Our continued success is the direct result of our focus on delivering innovative engineering solutions for blue chip customers who are investing in meeting national needs."

 

 

7 January 2014

 

 

 Enquiries:

 

Costain

Tel: 01628 842 444

Andrew Wyllie, Chief Executive

Tony Bickerstaff, Finance Director

Graham Read, Communications Director

College Hill

Tel: 020 7457 2020

Mark Garraway

Helen Tarbet

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUNSBRSAAARAR
Date   Source Headline
9th Jun 20263:25 pmRNSHolding(s) in Company
9th Jun 20267:00 amRNSCostain wins place on £700m TfL framework
3rd Jun 202610:30 amRNSTransaction in Own Shares
1st Jun 202610:31 amRNSTotal Voting Rights
27th May 20269:34 amRNSTransaction in Own Shares
22nd May 20261:00 pmRNSDirector/PDMR Shareholding
20th May 20269:55 amRNSTransaction in Own Shares
18th May 20261:51 pmRNSAdditional Listing
18th May 20269:39 amRNSDirector Declaration
14th May 20264:28 pmRNSResult of AGM
14th May 20267:00 amRNSAGM Trading Update
13th May 20265:14 pmRNSHolding(s) in Company
13th May 202610:19 amRNSTransaction in Own Shares
12th May 20264:01 pmRNSHolding(s) in Company
6th May 20269:35 amRNSTransaction in Own Shares
5th May 20262:08 pmRNSDirector/PDMR Shareholding
1st May 20264:08 pmRNSScrip Dividend Reference Price - Replacement
1st May 20269:08 amRNSTotal Voting Rights
30th Apr 20263:17 pmRNSDirector/PDMR Shareholding
29th Apr 202610:14 amRNSTransaction in Own Shares
27th Apr 202612:27 pmRNSScrip Dividend Reference Price
22nd Apr 20265:06 pmRNSDirector/PDMR Shareholding
22nd Apr 202611:48 amRNSTransaction in Own Shares
21st Apr 20265:15 pmRNSHolding(s) in Company
16th Apr 20264:59 pmRNSHolding(s) in Company
15th Apr 20263:16 pmRNSTransaction in Own Shares
15th Apr 20263:05 pmRNSDirector/PDMR Shareholding
14th Apr 20263:29 pmRNSDirector Declaration
13th Apr 202611:20 amRNSDirector/PDMR Shareholding
8th Apr 202610:30 amRNSTransaction in Own Shares
2nd Apr 202611:19 amRNSAnnual Financial Report
1st Apr 202610:30 amRNSTransaction in Own Shares
1st Apr 20269:30 amRNSDirector/PDMR Shareholding
1st Apr 20268:59 amRNSTotal Voting Rights
27th Mar 20263:35 pmRNSAdditional Listing
25th Mar 202610:30 amRNSTransaction in Own Shares
18th Mar 202610:30 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNS-RCostain Secures c.£45m Contract with Severn Trent
10th Mar 20267:01 amRNS£20m Share Buyback Programme
10th Mar 20267:01 amRNS£20m Share Buyback Programme
10th Mar 20267:00 amRNSFinal Results
4th Mar 20268:27 amRNSDirectorate change
3rd Mar 202610:57 amRNSHolding(s) in Company
2nd Mar 20267:00 amRNSCostain returns to FTSE 250
25th Feb 20266:00 pmRNSAshtead Group
24th Feb 20263:59 pmRNSDirector Declaration
23rd Feb 20262:59 pmRNSHolding(s) in Company
20th Feb 20264:19 pmRNSHolding(s) in Company
18th Feb 20261:55 pmRNSHolding(s) in Company
9th Feb 20262:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.